VERTEX PHARMACEUTICALS INCORPORATED Quotes Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 455.3 USD | +2.77% |
|
-0.35% | +11.91% |
| May. 31 | BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480 | MT |
| May. 31 | Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|
| Last | 446.88 $ | 441.13 $ | 443.05 $ | 455.34 $ |
| Volume | 1 379 608 | 967 463 | 975 367 | 2 362 709 |
| Change | -2.20% | -1.29% | +0.44% | +2.77% |
| Opening | 454.79 | 445.56 | 439.11 | 444.74 |
| High | 454.79 | 448.21 | 443.25 | 456.91 |
| Low | 445.22 | 440.56 | 435.57 | 443.47 |
Performance
| 1 day | +2.77% | ||
| 1 week | -0.35% | ||
| 1 month | +13.23% | ||
| 3 months | +5.22% | ||
| 6 months | +29.67% | ||
| Current year | +11.91% | ||
| 1 year | +40.70% | ||
| 3 years | +117.17% | ||
| 5 years | +174.00% | ||
| 10 years | +530.14% |
Volumes
marketsDaily volume
2 362 709
Estimated daily volume
2 362 709
Avg. Volume 20 sessions
1 104 293
Daily volume ratio
2.14
Avg. Volume 20 sessions USD
502 828 774.62
Record volume 1
42 258 300
Record volume 2
40 221 040
Record volume 3
25 236 840
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
117 502 029 236
Net sales (USD)
9 869 200 000
Number of employees
5 400
Sales / Employee (USD)
1 827 630
Free-Float
99.89 %
Free-Float capitalization (USD)
117 370 640 879
Average Daily Capital Traded
0.43%
Highs and lows
1 week
435.57
456.91
1 month
394.03457.66
Current year
391.01457.66
1 year
323.02457.66
3 years
176.36457.66
5 years
165.23457.66
10 years
63.68457.66
Indicators
Moving average 5 days
448.65
Moving average 20 days
431.53
Moving average 50 days
415.21
Moving average 100 days
420.17
Price spread / (MMA5)
-1.47%
Price spread / (MMA20)
-5.23%
Price spread / (MMA50)
-8.81%
Price spread / (MMA100)
-7.72%
STIM
RSI 9 days
59.14
RSI 14 days
62.07
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.77% | -0.35% | +11.91% | +40.70% | 118B | ||
| +1.06% | -0.49% | +11.60% | +34.05% | 106B | ||
| +1.87% | +3.76% | -4.68% | -3.38% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -6.84% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -29.18% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.24% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -33.39% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +48.49% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +4.43% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +186.12% | 8.87B | ||
| -1.71% | +3.60% | +7.26% | +53.59% | 7.75B | ||
| +0.09% | +2.20% | +11.89% | +39.70% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +25.16% | 7.42B | ||
| -7.66% | -3.38% | -33.51% | -37.11% | 7.29B | ||
| +0.78% | -0.78% | +234.55% | +183.39% | 6.87B | ||
| +4.40% | +5.47% | -9.57% | +11.89% | 6.32B | ||
| Average | +0.01% | +9.95% | +16.88% | +30.02% | ||
| Weighted average by Cap. | +1.11% | +3.45% | +9.87% | +27.23% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
8c849e6.pt4Mw6IN5NZmNwAE9hkaWVPKTNPvEG7ccO3MmcFA0yQ.xa5k-5Vslb08dlZenDRXHRerPOaDdz_uFKSkrZU0o2HAhGK0yjqigyxoZw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 455.3 | 706,408 | 1,434,405 |
| 03:59:59 pm | 455.7 | 175 | 727,997 |
| 03:59:59 pm | 455.7 | 100 | 727,822 |
| 03:59:59 pm | 455.6 | 700 | 727,722 |
| 03:59:59 pm | 455.6 | 100 | 727,022 |
| 03:59:59 pm | 455.5 | 219 | 726,922 |
| 03:59:59 pm | 455.5 | 500 | 726,703 |
| 03:59:59 pm | 455.5 | 500 | 726,203 |
| 03:59:59 pm | 455.5 | 293 | 725,703 |
| 03:59:59 pm | 455.5 | 119 | 725,410 |
Monthly variations
Annual change
| 2024 | +11.91% | ||
| 2023 | +40.90% | ||
| 2022 | +31.50% | ||
| 2021 | -7.08% | ||
| 2020 | +7.94% | ||
| 2019 | +32.13% | ||
| 2018 | +10.58% | ||
| 2017 | +103.42% | ||
| 2016 | -41.45% | ||
| 2015 | +5.92% | ||
| 2014 | +59.89% | ||
| 2013 | +77.33% | ||
| 2012 | +26.17% | ||
| 2011 | -5.20% | ||
| 2010 | -18.25% | ||
| 2009 | +41.05% | ||
| 2008 | +30.78% | ||
| 2007 | -37.92% | ||
| 2006 | +35.24% | ||
| 2005 | +161.78% | ||
| 2004 | +2.13% | ||
| 2003 | -34.70% | ||
| 2002 | -35.54% | ||
| 2001 | -65.61% | ||
| 2000 | +308.57% | ||
| 1999 | +17.65% | ||
| 1998 | -9.85% | ||
| 1997 | -18.01% | ||
| 1996 | +51.89% | ||
| 1995 | +76.67% | ||
| 1994 | -18.92% | ||
| 1993 | +89.74% | ||
| 1992 | -33.90% | ||
| 1991 | +63.89% |
- Stock Market
- Equities
- VRTX Stock
- Quotes Vertex Pharmaceuticals Incorporated
